Phase I single-dose trial of CORT 108297 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2010
At a glance
- Drugs CORT 108297 (Primary)
- Indications Weight gain
- Focus Adverse reactions
- Sponsors Corcept Therapeutics
- 26 Feb 2010 Status changed from planning to recruiting.
- 26 Feb 2010 Estimated study completion date is in the first half of 2010, according to a Corcept Therapeutics media release.
- 07 Jan 2010 New trial record.